{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:36:25Z","timestamp":1771058185874,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jgar.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:53:39Z","timestamp":1671774819000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0611-0094","authenticated-orcid":false,"given":"C\u00e9d\u00e9ric","family":"Schaub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Barnsteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladina","family":"Sch\u00f6nenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nando","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-7404","authenticated-orcid":false,"given":"Sarah","family":"Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0607-7159","authenticated-orcid":false,"given":"Werner C.","family":"Albrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Conen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-957X","authenticated-orcid":false,"given":"Michael","family":"Osthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.12.002_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","article-title":"Understanding the mechanisms and drivers of antimicrobial resistance","volume":"387","author":"Holmes","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2022.12.002_bib0003","article-title":"Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018","volume":"26","author":"Barnsteiner","year":"2021","journal-title":"Euro surveil"},{"key":"10.1016\/j.jgar.2022.12.002_bib0004","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1093\/jac\/dkx278","article-title":"Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey","volume":"72","author":"Glinz","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.12.002_bib0005","doi-asserted-by":"crossref","first-page":"w20135","DOI":"10.4414\/smw.2019.20135","article-title":"Appropriateness of antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence survey","volume":"149","author":"G\u00fcrtler","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jgar.2022.12.002_bib0006","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.mcna.2018.04.003","article-title":"Antimicrobial stewardship programs: principles and practice","volume":"102","author":"Cunha","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jgar.2022.12.002_bib0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3201\/eid1003.030252","article-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","volume":"10","author":"Albrich","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0008","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3201\/eid1809.111515","article-title":"Control of fluoroquinolone resistance through successful regulation","volume":"18","author":"Cheng","year":"2012","journal-title":"Australia. Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0009","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity","volume":"163","author":"Hecker","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2022.12.002_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrmicro2989","article-title":"Blooming'in the gut: how dysbiosis might contribute to pathogen evolution","volume":"11","author":"Stecher","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2022.12.002_bib0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0003134820942186","article-title":"Trends in antibiotic duration for complicated intra-abdominal infections: adaptation to current guidelines","volume":"87","author":"DeCesare","year":"2021","journal-title":"Am Surg"},{"key":"10.1016\/j.jgar.2022.12.002_bib0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QCO.0000000000000680","article-title":"Antibiotic treatment of common infections: more evidence to support shorter durations","volume":"33","author":"Smith","year":"2020","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.jgar.2022.12.002_bib0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/a-1497-0693","volume":"75","author":"Ewig","year":"2021","journal-title":"Pneumologie"},{"key":"10.1016\/j.jgar.2022.12.002_bib0014","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2022.12.002_bib0015","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0016","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2022.12.002_bib0017","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2020.6348","article-title":"Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial","volume":"323","author":"von Dach","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2022.12.002_bib0018","first-page":"1725","article-title":"[Shortening the antibiotherapy is in progress: get up to date!]","volume":"13","author":"Bonnemain","year":"2017","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.jgar.2022.12.002_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jhbp.518","article-title":"Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis","volume":"25","author":"Gomi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jgar.2022.12.002_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0021","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2022.12.002_bib0022","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jgar.2022.12.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10700","article-title":"Prevalence of Clinical Signs Within Reference Ranges Among Hospitalized Patients Prescribed Antibiotics for Pneumonia","volume":"3","author":"Klompas","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jgar.2022.12.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2007","article-title":"Assessment of the appropriateness of antimicrobial use in US hospitals","volume":"4","author":"Magill","year":"2021","journal-title":"JAMA network open"},{"key":"10.1016\/j.jgar.2022.12.002_bib0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","article-title":"Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial","volume":"397","author":"Dinh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2022.12.002_bib0026","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2022.12.002_bib0027","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotiac treatment in community-acquired pneumonia: a multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jgar.2022.12.002_bib0028","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jiac.2017.11.005","article-title":"Factors that affect the duration of antimicrobial therapy for cellulitis","volume":"24","author":"Inaoki","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2022.12.002_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115305","article-title":"Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT)","volume":"100","author":"Palit","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamadermatol.2019.0884","article-title":"Assessment of antibiotic treatment of cellulitis and erysipelas: a systematic review and meta-analysis","volume":"155","author":"Brindle","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jgar.2022.12.002_bib0031","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmi.2019.09.019","article-title":"Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial","volume":"26","author":"Cranendonk","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.12.002_bib0032","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1093\/cid\/ciz006","article-title":"Analysis of pooled phase III efficacy data for delafloxacin in acute bacterial skin and skin structure infections","volume":"68","author":"Giordano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.giec.2007.03.006","article-title":"Management of ascending cholangitis","volume":"17","author":"Kinney","year":"2007","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.jgar.2022.12.002_bib0034","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2022.12.002_bib0036","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.cmi.2015.03.023","article-title":"Implementing criteria-based early switch\/early discharge programmes: a European perspective","volume":"21","author":"Nathwani","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.12.002_bib0037","doi-asserted-by":"crossref","first-page":"e4499","DOI":"10.1093\/cid\/ciaa1372","article-title":"Antibiotic overuse after hospital discharge: a multi-hospital cohort study","volume":"73","author":"Vaughn","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0038","doi-asserted-by":"crossref","first-page":"w14512","DOI":"10.4414\/smw.2017.14512","article-title":"Evaluation of existing and desired antimicrobial stewardship activities and strategies in Swiss hospitals","volume":"147","author":"Osthoff","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jgar.2022.12.002_bib0039","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.2146\/ajhp170405","article-title":"Use of clinical decision support to identify i.v.-to-oral conversion opportunities and cost savings","volume":"75","author":"Carver","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jgar.2022.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciac104","article-title":"Antibiotic stewardship strategies and their association with antibiotic overuse after hospital discharge: an analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework","volume":"75","author":"Vaughn","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.12.002_bib0041","first-page":"325","article-title":"Epidemiology of ICU-acquired pneumonia","volume":"24","author":"Ferrer","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jgar.2022.12.002_bib0042","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/sur.2009.084","article-title":"Catheter-related vs. catheter-associated blood stream infections in the intensive care unit: incidence, microbiology, and implications","volume":"11","author":"Sihler","year":"2010","journal-title":"Surg Infect (Larchmt)"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:00:05Z","timestamp":1761991205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":42,"alternative-id":["S2213716522002673"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.12.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}